Sign in
4

Changes in Ownership

Actinium Pharmaceuticals, Inc. Filed Acc 0001213900-17-008254

Chairman & CEO bought 33,333 shares at $0.75 ($25,000)

From the SEC's structured data for this filing

Trades in this filing

SETH SANDESH · Chairman & CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2017-08-02 Purchase : show line 1 in the form +33,333 $0.75 $25,000 75,833 D
Open-market purchases · 33,333 sh · avg $0.75 · $25,000
Loading xslF345X03/f4080217seth_actiniumpharm.xml…